Method to increase oxygen in male and female sexual organs through the topical use of perfluorocarbons

• US 20110086923A1
• Filed: 07/27/2010
• Published: 04/14/2011
• Est. Priority Date: 07/28/2009
• Status: Abandoned Application

• Current Assignee: Tenax Therapeutics, Inc.
• Original Assignee: Tenax Therapeutics, Inc.
• Inventors: Kiral, Richard, Thompson, Deborah P., Stern, Chris
• Application Number:
  US12/804,696
• Publication Number:
  US 20110086923A1
• Time in Patent Office: Days
• US Class Current: 514/747
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/025 carbocyclic
• CPC Class Codes: A61K 31/165 having aromatic rings, e.g. colchicine, atenolol, progabide
• CPC Class Codes: A61K 36/54 Lauraceae (Laurel family), e.g. cinnamon or sassafras
• CPC Class Codes: A61P 15/00 Drugs for genital or sexual disorders for disorders of sex hormones A61P5/24; Contraceptives

Abstract

The subject application provides for a method of increasing oxygen level in a sex organ of a subject comprising topically administering to the subject an amount of a perfluorocarbon effective to increase the oxygen level in the sex organ of the subject. The subject application also provides for the use of a perfluorocarbon in the manufacture of a composition for increasing oxygen level in a sex organ of a subject. The subject application also provides for a composition comprising a perfluorocarbon for use in increasing oxygen level in a sex organ of a subject.

Claims

1. A method of increasing oxygen level in a sex organ of a subject comprising topically administering to the subject an amount of a perfluorocarbon effective to increase the oxygen level in the sex organ of the subject.

2. The method of claim 1, wherein after the administration of the perfluorocarbon, oxygen tension in the sex organ of the subject is increased.

3. The method of claim 1, wherein the sex organ is the genitalia.

4. The method of claim 1, wherein the perfluorocarbon is perfluoro(tert-butylcyclohexane).

5. The method of claim 1, wherein the perfluorocarbon is in the form of a gel.

6. The method of claim 5, wherein the gel comprises 20-90 wt % perfluorocarbon.

7. The method of claim 6, wherein the gel comprises 30-50 wt % perfluorocarbon.

8. The method of claim 5, wherein the gel further comprises a surfactant.

9. The method of any claim 1, wherein the perfluorocarbon is administered with a warming agent.

10. The method of claim 9, wherein the warming agent is capsaicin or cinnamon oil extract.

11. The method of claim 1, wherein the perfluorocarbon is administered with a cooling agent.

12. The method of claim 11, wherein the warming agent is menthol.

13. The method of claim 1, wherein the perfluorocarbon is administered with a lubricant.

14. The method of claim 13, wherein the lubricant is glycerol.

15. The method of claim 1, wherein the perfluorocarbon is administered periodically.

16. The method of claim 15, wherein the perfluorocarbon is administered once daily.

17. The method of claim 15, wherein the perfluorocarbon is administered twice daily.

18. The method of claim 1, wherein the subject is a mammal.

19. The method of claim 18, wherein the mammal is a human.

20. The method of claim 1, where in the subject is male.

21-22. -22. (canceled)